AboutBlogFDA EmployeeOver 40,000+ FDA inspection documents: 483s, EIRs, 483Rs

483 Changzhou Ruiming Pharmaceuticals, Sep 2018

$179 - Available for instant download

FDA investigators audited the Changzhou Ruiming Pharmaceuticals - Changzhou, China facility and issued inspectional observation (via FDA 483) on 13 Sep 2018.

Product Details

  • Inspection end: 13 Sep 2018
  • Location: Changzhou, China
  • FEI: 3007086821
Changzhou Ruiming Pharmaceuticals FDA inspection 483 Sep 2018

Related Products